For example, PhosphoPICK-based networks failed to show ABL activity in BCR-ABL driven cancers and GPS failed to show HER2-activity in any breast cancer sample, where HER2-activity is a driving oncogene in many of these samples. The gene discussed is ABL1; the disease is breast cancer.